Foster City, CA, United States of America

Yan Zhu

USPTO Granted Patents = 25 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 7.8

ph-index = 8

Forward Citations = 190(Granted Patents)

Company Filing History:

Cymabay Therapeutics, Inc.

patents

4. 2 out of 13

Advanced Medicine, Inc.

Kosan Biosciences Incorporated

patents

Years Active: 2002-2018

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9925189 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders (2018-03-27),

2. 9737537 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders (2017-08-22),

3. 8975258 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders (2015-03-10),

4. 8921350 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders (2014-12-30),

5. 8846675 - N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders (2014-09-30),

6. 8288384 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders (2012-10-16),

7. 8227495 - 2,4-disubsituted thiazoles and pharmaceutical compositions thereof (2012-07-24),

8. 8183381 - N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders (2012-05-22),

9. 8063021 - Ketolide anti-infective compounds (2011-11-22),

10. 7723470 - Glycopeptide derivatives and pharmaceutical compositions containing the same (2010-05-25),

11. 7714131 - Process for the stereoselective preparation of (−)-halofenate and derivatives thereof (2010-05-11),

12. 7638541 - 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine (2009-12-29),

13. 7622491 - Modulators of PPAR and methods of their preparation (2009-11-24),

14. 7432394 - Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines (2008-10-07),

15. 7323480 - Substituted triazoles as modulators of PPAR and methods of their preparation (2008-01-29),

Title: Innovator Spotlight: Yan Zhu's Contributions to Diabetes Treatment

Introduction: Yan Zhu, based in Foster City, California, is a prominent inventor in the field of pharmaceutical innovations, particularly focusing on treatments for diabetes and metabolic disorders. With an impressive portfolio of 25 patents, Yan has made significant strides in developing compounds and methods that seek to improve the quality of life for those suffering from these chronic conditions.

Latest Patents: Yan Zhu's latest contributions to the industry include groundbreaking patents related to heterocyclic receptor agonists aimed at treating Type II diabetes and other diseases associated with poor glycemic control. The methods and compounds developed by Yan are noted for their oral bioavailability, which represents a significant advancement in the treatment landscape for patients dealing with diabetes.

Career Highlights: Throughout his career, Yan has been associated with notable companies such as Metabolex, Inc. and Theravance, Inc. His work at these institutions has allowed him to spearhead numerous projects aimed at tackling metabolic diseases through innovative pharmaceutical solutions.

Collaborations: Yan's journey in research and development has been enriched by collaborations with talented professionals in the field. Notable colleagues include Peng Cheng and Jingyuan Ma, with whom he has worked closely on various projects targeting diabetes treatment.

Conclusion: Yan Zhu's dedication to improving healthcare through innovative treatment solutions is commendable. His extensive patent portfolio underscores his role as a leading inventor in the domain of diabetes treatment, paving the way for future advancements in the pharmacological landscape.

This text is generated by artificial intelligence and may not be accurate.